We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Optimizing Respiratory Therapy Resources by De-Implementing Low-Value Care.
- Authors
Fleming, Kellianne; George, Jessica L.; Bazelak, Sarah J.; Roeske, Julie A.; Biggs, Adam D.; Landry, Curtis M.; Lipchik, Randolph J.; Truwit, Jonathon D.
- Abstract
BACKGROUND: Our institution was experiencing a respiratory therapy staffing crisis during the COVID-19 pandemic, in part due to excessive workload. We identified an opportunity to reduce burden by limiting use of 3% hypertonic saline and/or N-acetylcysteine nebulizer therapies (3%HTS/NAC). METHODS: Leveraging the science of de-implementation, we established a policy empowering respiratory therapists to discontinue 3%HTS/NAC not meeting the American Association for Respiratory Care (AARC) Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients. After a 3-month period of educating physicians and advanced practice practitioners the policy went to into effect. Outcomes measured included monthly number of treatments, orders, and full-time employees associated with administering nebulized 3%HTS/NAC. RESULTS: Post policy activation, the monthly mean 3%HTS/NAC treatments were significantly reduced to 547.5 ± 284.3 from 3,565.2 ± 596.4 (P < .001) as were the associated monthly mean of full-time employees, 0.8 ± 0.41 from 5.1 ± 0.86 (P < .001). The monthly mean 3%HTS/NAC orders also fell to 93.8 ± 31.5 from 370.0 ± 46.9 (P < .001). Monthly mean non-3%HTS/NAC treatments remained stable; post policy was 3,089.4 ± 611.4 and baseline 3,279.6 ± 695.0 (P = 1.0). CONCLUSIONS: Implementing a policy that empowers respiratory therapists to promote adherence to AARC Clinical Guidelines reduced low-value therapies, costs, and staffing needs.
- Subjects
MEDICAL quality control; ACETYLCYSTEINE; KRUSKAL-Wallis Test; PROFESSIONS; MEDICAL care; LABOR demand; CONTINUING education units; SELF-efficacy; NEBULIZERS &; vaporizers; MEDICAL protocols; RESPIRATORY therapy; COST analysis; DECISION making; HOSPITAL respiratory therapy services; DESCRIPTIVE statistics; LEGAL compliance; MANAGEMENT; HYPERTONIC saline solutions; DECISION making in clinical medicine; DATA analysis software; COVID-19 pandemic; AMERICAN Association for Respiratory Care
- Publication
Respiratory Care, 2023, Vol 68, Issue 5, p559
- ISSN
0020-1324
- Publication type
Article
- DOI
10.4187/respcare.10712